查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888711

基于 CRISPR 的即时诊断市场规模、份额和趋势分析报告：按产品、技术、应用、最终用途、地区和细分市场预测（2025-2033 年）

CRISPR-based POC Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

基于 CRISPR 的即时诊断市场摘要

2024 年全球基于 CRISPR 的即时诊断市场规模估计为 5.0264 亿美元，预计到 2033 年将达到 17.8656 亿美元。

预计从 2025 年到 2033 年，该市场将以 15.41% 的复合年增长率成长。随着诊断能力向医疗点靠拢，市场正在扩张，这主要得益于医疗基础设施有限的地区越来越多地采用检测方法。

成本效益高、准确度高、操作简便，正推动其在全球医疗系统中广泛应用。战略合作正将创新带入市场，尤其是在医疗资源匮乏的地区。例如，2023年8月，Crisprbits与Molbio Diagnostics Limited合作推出了一款基于CRISPR技术的就地检验，该产品提供了一种经济高效、创新且高度精准的诊断解决方案，同时拓展了市场机会，并革新了照护现场。

此外，感染疾病流行是推动市场成长的主要因素。包括流感、结核病、病毒性肝炎和性行为感染感染（STI）在内的全球感染疾病负担正在稳定加重，因此迫切需要快速、准确且低成本的诊断解决方案。 2025年2月，世界卫生组织指出，季节性流感仍是重要的全球健康问题，每年报告的病例估计达10亿例（其中300万至500万例为重症）。这种感染疾病每年导致29万至65万人死于呼吸道疾病，凸显了其对全球公共卫生系统造成的毁灭性影响。尤其值得注意的是，99%的五岁以下儿童流感相关下呼吸道感染疾病死亡病例发生在开发中国家，这凸显了医疗保健服务取得和治疗结果方面存在的严重差距。此外，世界卫生组织于2025年9月宣布，全球15至49岁人口每天感染超过100万例可治疗的性行为感染（STI），其中大多数为无症状感染者。据估计，到2022年，约有800万15至49岁成年人将感染梅毒。

此外，由于全球遗传疾病负担日益加重，以及对快速、准确且经济高效的检测需求不断增长，市场正在迅速扩张。传统的PCR和RT-PCR方法虽然准确，但需要复杂的设备、训练有素的人员以及较长的检测时间，这限制了它们在资源有限和分散式环境中的实用性。 CRISPR/Cas系统（Cas9、Cas12和Cas13）具有无与伦比的灵敏度、特异性和可程式设计，能够在1小时内以单核苷酸分辨率检测癌症和基因突变。诸如SHERLOCK和DETECTR之类的平台透过简单的侧向流动或萤光检测方法即可实现阿托摩尔级的灵敏度，使其成为照护现场（POC）的理想选择。 CRISPR诊断技术将分子层面的准确性与操作简便性和扩充性结合，正在改变全球诊断格局，并推动其在医院、诊所和分散式检查项目中的应用。

此外，全球亟需解决抗菌素抗药性（AMR）问题，这是现代医疗保健领域最迫切的挑战之一，也推动了对基于CRISPR技术的即时诊断的需求。世界各地的医院和医疗保健系统都面临越来越大的压力，需要快速检测和控制抗药性感染疾病，以防止代价高昂的疫情爆发并改善患者预后。基于CRISPR技术的诊断提案具有强大的价值：它们提供快速、高度准确且易于使用的检测解决方案，从而减少对中心实验室的依赖。这些技术使临床医生能够做出早期且准确的治疗决策，最大限度地减少抗生素滥用并优化资源利用。其便携性和扩充性使其对资源有限的环境和即时诊断应用尤为具有吸引力。 CRISPR诊断技术兼具准确性、速度和易用性，正在革新感染疾病诊断市场，并为临床决策效率树立新的标准。例如，2025年2月，印度Crisprbits公司开发了PathCrisp，这是一个用于检测医院获得性感染中抗生素抗药性的分子诊断平台。该技术旨在实现对抗菌素抗药性（AMR）的早期检测，这是一个全球性的健康问题，尤其是在加护病房（ICU）中。

目录

第一章 基于CRISPR技术的即时诊断市场：调查方法与范围

2. 基于 CRISPR 的即时诊断市场：执行摘要

  • 市场概览
  • 产品
  • 技术概述
  • 应用概述
  • 最终用途概述
  • 竞争格局概述

3. 基于 CRISPR 的即时诊断市场的变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 去中心化且易于使用的诊断技术
    • 全球感染疾病和遗传疾病负担日益加重
    • 应对抗菌素抗药性（AMR）的迫切需求
  • 市场限制因素分析
    • 监管和临床检验障碍
    • 生产扩充性和成本限制
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 基于 CRISPR 的即时诊断市场：按产品分類的估算和趋势分析

  • 基于 CRISPR 的即时诊断市场：产品差异分析
  • 设备/器材
  • 检测试剂盒和试剂
  • 软体和连接平台

第五章 基于 CRISPR 的即时诊断市场：按技术分類的估算和趋势分析

  • 基于 CRISPR 的即时诊断市场：按技术分類的差异分析
  • 基于Cas9的
  • 基于 Cas12 的（DETECTR 技术）
  • 基于 Cas13 的（SHERLOCK 技术）
  • 其他新兴的Cas系统

第六章 基于 CRISPR 的即时诊断市场：按应用分類的估算和趋势分析

  • 基于 CRISPR 的即时诊断市场：按应用分類的差异分析
  • 感染疾病诊断
  • 基因疾病检测
  • 肿瘤诊断
  • 抗菌素抗药性（AMR）检测
  • 其他用途

7. 基于 CRISPR 的即时诊断市场：按最终用途分類的估算和趋势分析

  • 基于 CRISPR 的即时诊断市场：按最终用途分類的差异分析
  • 医院和诊所
  • 诊断检查室
  • 居家照护/居家检测
  • 其他的

8. 基于 CRISPR 的即时诊断市场：区域业务分析

  • 区域市场概览
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合资
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • Mammoth Biosciences, Inc.
    • OraSure Technologies, Inc.（Sherlock Biosciences）
    • Caspr Biotech
    • GenScript
    • Integrated DNA Technologies, Inc.
    • Synthego
    • Revvity Discovery Limited
    • Twist Bioscience
    • Crisprbits
    • Danaher Corporation（Cepheid）
Product Code: GVR-4-68040-820-3

CRISPR-based POC Diagnostics Market Summary

The global CRISPR-based POC diagnostics market size was estimated at USD 502.64 million in 2024 and is projected to reach USD 1,786.56 million by 2033, growing at a CAGR of 15.41% from 2025 to 2033. The market is expanding as diagnostic capabilities shift closer to the point of care, supported by broader availability of testing in regions with limited healthcare infrastructure.

Cost-effectiveness, high accuracy, and ease of use propel adoption across healthcare systems globally. Strategic partnerships are bringing innovations into the market, specifically in underserved settings. For instance, in August 2023, Crisprbits partnered with Molbio Diagnostics Limited to launch CRISPR-based point-of-care tests to provide cost-effective, innovative, and highly accurate diagnostic solutions while expanding market opportunities and transforming point-of-care diagnostics.

Furthermore, the increasing prevalence of infectious diseases is a major factor propelling the growth of the market. The global burden of infectious conditions such as influenza, tuberculosis, viral hepatitis, and sexually transmitted infections (STIs) has risen steadily, creating an urgent need for rapid, accurate, and affordable diagnostic solutions. In February 2025, the WHO noted that seasonal influenza continues to pose a significant global health burden, with an estimated one billion cases reported annually, including 3-5 million cases of severe illness. The infection is responsible for 290,000 to 650,000 respiratory deaths each year, underscoring its substantial impact on public health systems worldwide. Significantly, 99% of influenza-related lower respiratory tract infection deaths among children under five occur in developing countries, highlighting stark inequalities in healthcare access and outcomes. Moreover, the WHO stated in September 2025 that every day, more than 1 million treatable sexually transmitted infections (STIs) are acquired in people aged 15 to 49 worldwide, with the majority of them asymptomatic. In 2022, an estimated 8 million adults aged 15 to 49 were infected with syphilis.

In addition, the market is expanding rapidly due to the increasing global burden of genetic diseases and the growing demand for rapid, accurate, and cost-effective testing. Traditional PCR and RT-PCR methods, although precise, require sophisticated equipment, trained personnel, and lengthy turnaround times, which limit their utility in resource-constrained and decentralized settings. CRISPR/Cas systems (Cas9, Cas12, and Cas13) offer unparalleled sensitivity, specificity, and programmability, enabling the detection of cancers and genetic variants with single-nucleotide resolution within an hour. Platforms like SHERLOCK and DETECTR have achieved attomolar sensitivity with simple lateral flow or fluorescence readouts, making them excellent candidates for point-of-care applications. CRISPR diagnostics, which combine molecular precision with operational simplicity and scalability, are reshaping the global diagnostics landscape and driving adoption in hospitals, clinics, and decentralized testing programs.

Moreover, the growing global urgency to address antimicrobial resistance (AMR), which has become one of the most important challenges in modern healthcare, is boosting the demand for the CRISPR-based POC diagnostics. Hospitals and healthcare systems worldwide are under increasing pressure to rapidly detect and contain antibiotic-resistant infections, thereby preventing costly outbreaks and improving patient outcomes. CRISPR-based diagnostic platforms offer a compelling value proposition by delivering fast, highly accurate, and easy-to-use testing solutions that reduce reliance on centralized laboratory facilities. These technologies enable clinicians to make early and targeted treatment decisions, minimizing the misuse of antibiotics and optimizing resource utilization. Their portability and scalability make them particularly attractive for deployment in resource-limited settings and point-of-care environments. By combining precision, speed, and accessibility, CRISPR diagnostics are revolutionizing the infectious disease diagnostics market and establishing new benchmarks for efficiency in clinical decision-making. For instance, in February 2025, Crisprbits (India) developed PathCrisp, a molecular diagnostic platform that uses CRISPR technology to detect antibiotic resistance in hospital-acquired infections. The technology is intended to allow early identification of AMR, a major worldwide health concern, particularly in intensive care units (ICUs).

Global CRISPR-based POC Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global CRISPR-based POC diagnostics market report based on product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments/Devices
  • Assay Kits and Reagents
  • Software and Connectivity Platforms
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Cas9-Based
  • Cas12-Based (DETECTR Technology)
  • Cas13-Based (SHERLOCK Technology)
  • Other Emerging Cas Systems
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Infectious Disease Diagnostics
  • Genetic Disorder Testing
  • Oncology Diagnostics
  • Antimicrobial Resistance (AMR) Testing
  • Other Applications
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Homecare / At-Home Testing
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. CRISPR-based POC Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. CRISPR-based POC Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product
  • 2.3. Technology Snapshot
  • 2.4. Application Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. CRISPR-based POC Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Decentralized and accessible diagnostics
    • 3.4.2. Rising global burden of infectious and genetic diseases
    • 3.4.3. Growing need to combat antimicrobial resistance (AMR)
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory and clinical validation barriers
    • 3.5.2. Manufacturing scalability and cost constraints
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. CRISPR-based POC Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. CRISPR-based POC Diagnostics Market: Product Movement Analysis
  • 4.2. Instruments/Devices
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Assay Kits and Reagents
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Software and Connectivity Platforms
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. CRISPR-based POC Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. CRISPR-based POC Diagnostics Market: Technology Movement Analysis
  • 5.2. Cas9-Based
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Cas12-Based (DETECTR Technology)
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Cas13-Based (SHERLOCK Technology)
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Other Emerging Cas Systems
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. CRISPR-based POC Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. CRISPR-based POC Diagnostics Market: End Use Movement Analysis
  • 6.2. Infectious Disease Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Genetic Disorder Testing
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Oncology Diagnostics
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Antimicrobial Resistance (AMR) Testing
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. CRISPR-based POC Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. CRISPR-based POC Diagnostics Market: End Use Movement Analysis
  • 7.2. Hospitals and Clinics
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Homecare / At-Home Testing
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Others
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. CRISPR-based POC Diagnostics Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America CRISPR-based POC Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. Middle East & Africa
    • 8.6.1. Middle East & Africa CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Mammoth Biosciences, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. OraSure Technologies, Inc. (Sherlock Biosciences)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Caspr Biotech
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. GenScript
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Integrated DNA Technologies, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Synthego
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Revvity Discovery Limited
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Twist Bioscience
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Crisprbits
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Danaher Corporation (Cepheid)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global CRISPR-based POC Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 11 North America CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 North America CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Canada CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Canada CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 28 Europe CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Europe CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 UK CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 UK CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Germany CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Germany CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 40 France CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 France CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Italy CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Italy CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Spain CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Spain CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Sweden CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Sweden CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Norway CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 56 Norway CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 Norway CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Denmark CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Denmark CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 Japan CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Japan CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 China CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 China CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 India CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 78 India CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 81 Australia CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 Australia CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 Thailand CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 Thailand CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 South Korea CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 South Korea CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Latin America CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 99 Brazil CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 103 Argentina CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 112 South Africa CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 119 UAE CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 120 UAE CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global CRISPR-based POC diagnostics market - Key market driver analysis
  • Fig. 7 Global CRISPR-based POC diagnostics market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global CRISPR-based POC diagnostics market - Porter's analysis
  • Fig. 10 Global CRISPR-based POC diagnostics market - PESTEL analysis
  • Fig. 11 Global CRISPR-based POC diagnostics market: Product outlook key takeaways
  • Fig. 12 Global CRISPR-based POC diagnostics market: Product movement analysis
  • Fig. 13 Instruments/devices market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Assay kits and reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Software and connectivity platforms market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global CRISPR-based POC diagnostics market: Technology outlook key takeaways
  • Fig. 17 Global CRISPR-based POC diagnostics market: Technology movement analysis
  • Fig. 18 Cas9-based market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Cas12-based (DETECTR technology) market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Cas13-based (SHERLOCK technology) market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Other emerging Cas systems market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global CRISPR-based POC diagnostics market: Application outlook key takeaways
  • Fig. 23 Global CRISPR-based POC diagnostics market: Application movement analysis
  • Fig. 24 Infectious disease diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Genetic disorder testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Oncology diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Antimicrobial resistance (AMR) testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Other applications market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Global CRISPR-based POC diagnostics market: End Use outlook key takeaways
  • Fig. 30 Global CRISPR-based POC diagnostics market: End Use movement analysis
  • Fig. 31 Hospitals and clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Homecare / at-home testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global CRISPR-based POC diagnostics market: Regional movement analysis
  • Fig. 37 North America CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 Canada CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 41 Europe CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 UK CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 France CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Italy CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 47 Denmark CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 49 Norway CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 51 Japan CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 China CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 53 India CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East & Africa CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 South Africa CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 62 Saudi Arabia CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 UAE CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 65 Strategy framework